Detalles de la búsqueda
1.
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
J Med Virol
; 95(6): e28884, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342886
2.
Heterogeneity assessment of vaccine-induced effects using point-of-care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2.
J Clin Lab Anal
; 36(7): e24545, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678628
3.
Survey of the current status of subclinical coronavirus disease 2019 (COVID-19).
J Infect Chemother
; 26(12): 1294-1300, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958395
4.
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.
Clin Exp Hypertens
; 41(7): 637-644, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373408
5.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Cardiovasc Endocrinol Metab
; 12(4): e0292, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779602
6.
Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Intern Med
; 61(2): 159-165, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34744105
7.
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Intern Med
; 61(20): 3053-3062, 2022 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945024
8.
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Diabetes Res Clin Pract
; 185: 109231, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131376
9.
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models.
J Diabetes Investig
; 12(1): 74-81, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32506833
10.
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Diabetes Technol Ther
; 23(2): 110-119, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721227
11.
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
J Diabetes Res
; 2019: 9415313, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31781668
12.
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
Diab Vasc Dis Res
; 16(1): 103-107, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30284913
13.
Efficacy of once-weekly intravenous administration of epoetin-beta as a maintenance treatment for anemia in Japanese hemodialysis patients: a multicenter, open-label clinical study.
Ther Apher Dial
; 12(6): 469-74, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19140845
Resultados
1 -
13
de 13
1
Próxima >
>>